DUBLIN--(BUSINESS WIRE)--The "CNS Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for CNS Therapeutics in US$ Million by the following Product Groups:
- Anti-Alzheimer's
- Anti-Parkinson's
- Anti-Epilepsy
- Pain Management
- Anti-Psychotics
- Anti-Depressants
- Others
The report profiles 162 companies including many key and niche players such as:
- AbbVie Inc.
- Alkermes Plc.
- Allergan, Plc
- Amneal Pharmaceuticals, LLC
- AstraZeneca Plc
- BIAL Group
- Bristol-Myers Squibb
- Eisai Co., Ltd.
- Endo Pharmaceuticals Inc.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Fabre-Kramer Pharmaceuticals, Inc.
- GlaxoSmithKline
- H. Lundbeck A/S
- Johnson & Johnson
- Janssen Pharmaceuticals, Inc.
- Merck & Co., Inc.
- Neurocrine Biosciences, Inc.
- Novartis AG
- Otsuka Pharmaceutical Co., Ltd.
- Pfizer, Inc.
- Purdue Pharma L.P.
- Sanofi S.A
- Shire Plc
- Strides Shasun Limited
- Sumitomo Dainippon Pharma Co., Ltd.
- Sunovion Pharmaceuticals, Inc.
- Takeda Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
- UCB Group
Key Topics Covered:
1. Industry Overview
2. Market Analysis By Therapeutic Categories
3. Growth Drivers & Market Trends
4. Product Overview
5. Innovations
6. Product Introductions/Innovations & R&D Breakthroughs
7. Recent Industry Activity
8. Focus On Select Global Players
9. Global Market Perspective
Total Companies Profiled: 162 (including Divisions
Subsidiaries 183)
- The United States (79)
- Canada (13)
- Japan (15)
-
Europe (50)
- France (5)
- Germany (9)
- The United Kingdom (9)
- Italy (2)
- Spain (3)
- Rest of Europe (22)
- Asia-Pacific (Excluding Japan) (19)
- Middle East (4)
- Latin America (1)
- Africa (2)
For more information about this report visit https://www.researchandmarkets.com/research/kgc75c/cns_therapeutics?w=4
